Impact of Serotherapy on Immune Reconstitution and Survival Outcomes After Stem Cell Transplantations in Children: Thymoglobulin Versus Alemtuzumab

Author(s):
Willemsen, L.; Jol-van der Zijde, C.M.; Admiraal, R.; Putter, H.; Jansen-Hoogendijk, A.M.; Ostaijen-ten Dam, M.M.; Wijnen, J.T. (0000-0003-2805-6922); Kesteren, C. van; Waaijer, J.L.M.; Lankester, A.C.; Bredius, R.G.M.; Tol, M.J.D. van (0000-0003-1600-4279)
Published
2015
Publication type
Article / Letter to editor
Antithymocyte globulinAlemtuzumabHematopoietic stem cell transplantationImmune reconstitutionSurvivalChildren
Date issued
2015-03-31
Language
English
Is part of
Biology of Blood and Marrow Transplantation (2015), Vol. 21, no. 3, p. 473-482
hdl
1887/103398
doi
10.1016/j.bbmt.2014.11.674